Congo-Kinshasa: DR Congo Receives 70,000 Ebola Vaccine Doses As Bundibugyo Outbreak Spreads

What the report says

The Democratic Republic of the Congo is set to receive 70,000 doses of the Ervebo Ebola vaccine from the UN-backed International Coordinating Group, following a request from the government in Kinshasa and approval for release from the global stockpile. According to UN News, the shipment is intended to protect frontline communities as the country faces a rapidly expanding Ebola outbreak linked to the Bundibugyo strain.

The World Health Organization said the vaccine is not known to be proven against Bundibugyo Ebola, although early laboratory and animal findings suggest it may offer some protection. Of the doses allocated, 20,000 are being reserved for a clinical trial in the DRC, while the remaining 50,000 will go to health workers. The allocation is meant to help generate evidence on whether the vaccine can be used more broadly in future outbreaks.

UN figures cited in the report said the outbreak, declared on 15 May, has become the country’s deadliest on record, with 2,325 deaths and 5,021 total cases reported by Wednesday. More than 160 health workers have been infected and 40 have died. The article also noted that insecurity in eastern Congo, including fighting involving M23 and other armed groups, has complicated contact tracing, access to health centers and safe burials, making outbreak control harder.